DN Group AG (ISIN: DE000A3DW408) announced that its subsidiary Algene Holding SE has completed the first harvest of high-purity microalgae, achieving a yield of 4,500 litres. This milestone signifies the transition from scaling to series production, positioning Algene to supply raw materials for cosmetics, food, and pharmaceutical industries. The production platform, developed in collaboration with the Technical University of Munich, is now operational.
Algene has engaged in discussions with several renowned cosmetics companies and has scheduled an initial delivery to a leading German cosmetics manufacturer in the coming days. This first batch will be used primarily for laboratory testing and validation of active ingredients. The high purity of the microalgae makes them suitable for quality-critical products, addressing a growing demand for sustainable bio-based raw materials.
The microalgae market is expanding rapidly, with the European Commission projecting growth to approximately 9 billion euros by 2030 in Europe alone. Algae are increasingly recognized as a strategic resource for the bioeconomy, applicable in nutrition, cosmetics, life sciences, and aquaculture. Algene Holding positions itself as an industrial platform for controlled microalgae production in this dynamic market.
Ole Nixdorff, CEO of DN Group, commented: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."
DN Group AG invests in impact companies with high growth opportunities in future industries such as AI, mobility, circular economy, food, health, and energy, and supports them in successful IPOs. For more information, visit www.dn-ag.com or view the original release on www.newmediawire.com.
